{"transactions":[{"id":851494,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":29016,"kind":"person","name":"Keenan Greg","position":1,"cik":"0002044006","reported_name":"Keenan Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-10T20:25:53.000Z","date":"2026-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":8069,"price":14.32,"value":115548.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":154449,"source":{"system":"sec-edgar","filing":"0001600620-26-000024","document":"wk-form4_1773174347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044006/000160062026000024/wk-form4_1773174347.xml","form_type":"4"}},{"id":868938,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":29016,"kind":"person","name":"Keenan Greg","position":1,"cik":"0002044006","reported_name":"Keenan Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T21:13:25.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":67870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":67870,"derivative":{"exercise_price":13.97,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":67870},"source":{"system":"sec-edgar","filing":"0001600620-26-000020","document":"wk-form4_1772572400.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2044006/000160062026000020/wk-form4_1772572400.xml","form_type":"4"}},{"id":868937,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":29016,"kind":"person","name":"Keenan Greg","position":1,"cik":"0002044006","reported_name":"Keenan Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:13:25.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":40586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four\nprogressively higher target prices, with respective one year retention periods per tranche achievement."}],"balance_after":162518,"source":{"system":"sec-edgar","filing":"0001600620-26-000020","document":"wk-form4_1772572400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044006/000160062026000020/wk-form4_1772572400.xml","form_type":"4"}},{"id":922356,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":29016,"kind":"person","name":"Keenan Greg","position":1,"cik":"0002044006","reported_name":"Keenan Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-03T21:49:18.000Z","date":"2026-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":11552,"price":14.53,"value":167850.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":121932,"source":{"system":"sec-edgar","filing":"0002044006-26-000002","document":"wk-form4_1770155355.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044006/000204400626000002/wk-form4_1770155355.xml","form_type":"4"}},{"id":1075053,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":29016,"kind":"person","name":"Keenan Greg","position":1,"cik":"0002044006","reported_name":"Keenan Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-05T20:07:28.000Z","date":"2025-08-01","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":10.5,"value":210000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.48 to $10.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":133484,"source":{"system":"sec-edgar","filing":"0001600620-25-000095","document":"wk-form4_1754424444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044006/000160062025000095/wk-form4_1754424444.xml","form_type":"4"}},{"id":1217850,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":29016,"kind":"person","name":"Keenan Greg","position":1,"cik":"0002044006","reported_name":"Keenan Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-07T22:25:05.000Z","date":"2025-03-07","kind":"sale","planned":false,"acquired":false,"shares":8305,"price":8.23,"value":68350.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 6, 2023 grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":153484,"source":{"system":"sec-edgar","filing":"0001600620-25-000026","document":"wk-form4_1741386297.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044006/000160062025000026/wk-form4_1741386297.xml","form_type":"4"}},{"id":1230191,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":29016,"kind":"person","name":"Keenan Greg","position":1,"cik":"0002044006","reported_name":"Keenan Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-05T01:59:49.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":95570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":95570,"derivative":{"exercise_price":7.55,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":95570},"source":{"system":"sec-edgar","filing":"0001600620-25-000022","document":"wk-form4_1741139983.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2044006/000160062025000022/wk-form4_1741139983.xml","form_type":"4"}},{"id":1230190,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":29016,"kind":"person","name":"Keenan Greg","position":1,"cik":"0002044006","reported_name":"Keenan Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:59:49.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":12239,"price":8,"value":97912.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the January 30, 2024 grant."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.79 to $8.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":161789,"source":{"system":"sec-edgar","filing":"0001600620-25-000022","document":"wk-form4_1741139983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2044006/000160062025000022/wk-form4_1741139983.xml","form_type":"4"}},{"id":1230189,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":29016,"kind":"person","name":"Keenan Greg","position":1,"cik":"0002044006","reported_name":"Keenan Greg","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:59:49.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":62583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four\nprogressively higher target prices, with respective one year retention periods per tranche achievement."}],"balance_after":174028,"source":{"system":"sec-edgar","filing":"0001600620-25-000022","document":"wk-form4_1741139983.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2044006/000160062025000022/wk-form4_1741139983.xml","form_type":"4"}}]}